Cleveland Clinic's chief digital officer on ambient scribes, sepsis prediction, and what comes next
-
By
-
Lisa Astor
-
September 17, 2026
-
7 min
By
Lisa Astor
September 17, 2026
by Lisa Astor
September 17, 2026
Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.
September 15, 2026
Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.
September 4, 2026
Researchers compared full‐pressure and low‐pressure external counterpulsation during a 12‐month trial in patients with clinically diagnosed early Alzheimer disease.
September 11, 2026